Totally agree with the sentiment that Patterson would have been terrific to have on board throughout the last year.

Everyone can see what trouble Pourhassan has communicating on these conference calls.

Do you think its any different when Pourhassan communicates with the FDA?

It doesn't even matter that Patterson is expert in the subject matter.

He can form complete thoughts and speak them in a clear fashion.